Genome‐wide hypermethylation is closely associated with abnormal expression of genes involved in neural development in induced pluripotent stem cells derived from a Down syndrome mouse model

• Published in: Cell biology international 2021-07, Vol.45 (7), p.1383-1392
• Main Authors: Xi, Jiao‐jiao, Yang, Guan‐heng, Liu, Yan‐na, Qiu, Jia‐jun, Gong, Xiu‐li, Yan, Jing‐bin, Zeng, Fanyi
• Format: Article
• Language: English
• Subjects: Chromosome 21; DNA methylation; Down syndrome; Down's syndrome; Embryos; Gene expression; Genomes; induced pluripotent stem cells; Intellectual disabilities; methylation; Nervous system; neural development; Neurodevelopment; Neurogenesis; Neuropathy; Phenotypes; Pluripotency; Stem cell transplantation; Stem cells; Tc1 mouse model
• ISSN: 1065-6995; 1095-8355
• DOI: 10.1002/cbin.11560

Mental retardation is the main clinical manifestation of Down syndrome (DS), and neural abnormalities occur during the early embryonic period and continue throughout life. Tc1, a model mouse for DS, carries the majority part of the human chromosome 21 and has multiple neuropathy phenotypes similar to patients with DS. To explore the mechanism of early neural abnormalities of Tc1 mouse, induced pluripotent stem (iPS) cells from Tc1 mice were obtained, and genome‐wide gene expression and methylation analysis were performed for Tc1 and wild‐type iPS cells. Our results showed hypermethylation profiles for Tc1 iPS cells, and the abnormal genes were shown to be related to neurodevelopment and distributed on multiple chromosomes. In addition, important genes involved in neurogenesis and neurodevelopment were shown to be downregulated in Tc1 iPS cells. In short, our study indicated that genome‐wide hypermethylation leads to the disordered expression of genes associated with neurodevelopment in Tc1 mice during early development. Overall, our work provided a useful reference for the study of the molecular mechanism of nervous system abnormalities in DS.